• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

NUDT22 Polyklonaler Antikörper

NUDT22 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 20761-1-PBS

Synonyme

Filter:
  • Western Blot (WB) analysis of K-562 cells using NUDT22 Polyclonal antibody (20761-1-AP)

    WB analysis of K-562 using 20761-1-AP (same clone as 20761-1-PBS)

    K-562 cells were subjected to SDS PAGE followed by western blot with 20761-1-AP (NUDT22 antibody) at dilution of 1:2500 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 20761-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

20761-1-PBS bindet in WB, Indirect ELISA NUDT22 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen NUDT22 fusion protein Ag14711
Vollständiger Name nudix (nucleoside diphosphate linked moiety X)-type motif 22
Berechnetes Molekulargewicht 303 aa, 33 kDa
Beobachtetes Molekulargewicht33 kDa
GenBank-ZugangsnummerBC006129
Gene symbol NUDT22
Gene ID (NCBI) 84304
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Human NUDT22 is a Mg2+-dependent UDP-glucose and UDP-galactose hydrolase, producing UMP and glucose 1-phosphate or galactose 1-phosphate. NUDT22 expression is consistently elevated in cancer tissues and high NUDT22 expression correlates with worse survival outcomes in patients.